Upgrade to FINVIZ Elite to get real-time quotes, intraday charts, and advanced charting tools. Subscribe to Elite

LLY

Lilly(Eli) & Co

Jan 16 • 04:00PM ET

1,038.40

+5.43 0.53 %

Healthcare • Drug Manufacturers - General • USA • NYSE

Peers: NVO JNJ ABBV MRK AZN AMGN PFE SNY BMY GSK

| Held by: VTI VOO IVV SPY VUG XLV VIG IWF VHT IVW

Scroll to Statements

Index	S&P 500	P/E	51.36	EPS (ttm)	20.22	Insider Own	9.92%	Shs Outstand	945.84M	Perf Week	-2.37%
Market Cap	981.69B	Forward P/E	31.72	EPS next Y	32.74	Insider Trans	-4.20%	Shs Float	851.56M	Perf Month	-1.51%
Enterprise Value	1014.34B	PEG	0.69	EPS next Q	7.20	Inst Own	73.11%	Short Float	0.82%	Perf Quarter	26.73%
Income	18.41B	P/S	16.52	EPS this Y	83.17%	Inst Trans	-1.13%	Short Ratio	1.99	Perf Half Y	34.56%
Sales	59.42B	P/B	41.28	EPS next Y	37.59%	ROA	19.33%	Short Interest	6.97M	Perf YTD	-3.38%
Book/sh	25.16	P/C	99.03	EPS next 5Y	46.12%	ROE	96.82%	52W High	1133.95 -8.43%	Perf Year	39.06%
Cash/sh	10.49	P/FCF	105.88	EPS past 3/5Y	24.14% 18.77%	ROIC	28.47%	52W Low	623.78 66.47%	Perf 3Y	188.12%
Dividend Est.	5.88 (0.57%)	EV/EBITDA	35.86	Sales past 3/5Y	16.73% 15.08%	Gross Margin	83.03%	Volatility	3.02% 2.72%	Perf 5Y	458.46%
Dividend TTM	6.00 (0.58%)	EV/Sales	17.07	EPS Y/Y TTM	120.94%	Oper. Margin	44.41%	ATR (14)	31.93	Perf 10Y	1178.03%
Dividend Ex-Date	Feb 13, 2026	Quick Ratio	1.24	Sales Y/Y TTM	45.41%	Profit Margin	30.99%	RSI (14)	46.00	Recom	1.55
Dividend Gr. 3/5Y	15.21% 15.05%	Current Ratio	1.55	EPS Q/Q	479.29%	SMA20	-3.00%	Beta	0.39	Target Price	1191.62
Payout	44.39%	Debt/Eq	1.79	Sales Q/Q	53.87%	SMA50	-0.37%	Rel Volume	1.09	Prev Close	1032.97
Employees	47000	LT Debt/Eq	1.72	Earnings	Oct 30 BMO	SMA200	23.66%	Avg Volume	3.51M	Price	1038.40
IPO	Jul 09, 1970	Option/Short	Yes / Yes	EPS/Sales Surpr.	23.33% 9.64%	Trades		Volume	3,813,919	Change	0.53%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-07-26	Resumed	UBS	Buy	$1250
Dec-16-25	Upgrade	Daiwa Securities	Neutral → Buy	$1230
Dec-15-25	Reiterated	Goldman	Buy	$951 → $1145
Dec-15-25	Reiterated	BofA Securities	Buy	$1286 → $1268
Nov-13-25	Initiated	Scotiabank	Sector Outperform	$1165
Nov-10-25	Upgrade	Leerink Partners	Market Perform → Outperform	$1104
Oct-20-25	Reiterated	BMO Capital Markets	Outperform	$840 → $930
Oct-14-25	Upgrade	Erste Group	Hold → Buy
Sep-17-25	Downgrade	Berenberg	Buy → Hold	$830
Aug-27-25	Upgrade	HSBC Securities	Reduce → Hold	$700
Aug-18-25	Downgrade	Daiwa Securities	Outperform → Neutral	$700
Aug-07-25	Downgrade	Leerink Partners	Outperform → Market Perform	$715
Jun-05-25	Downgrade	Erste Group	Buy → Hold
Apr-28-25	Downgrade	HSBC Securities	Buy → Reduce	$1150 → $700
Apr-22-25	Initiated	Cantor Fitzgerald	Overweight	$975
Dec-10-24	Resumed	BofA Securities	Buy	$997
Nov-15-24	Initiated	Wolfe Research	Outperform	$1000
Oct-17-24	Initiated	Bernstein	Outperform	$1100
Sep-13-24	Resumed	Citigroup	Buy	$1060
Aug-12-24	Upgrade	Deutsche Bank	Hold → Buy	$1025

Show Previous Ratings

Jan-17-26 02:00PM	Could Acquiring Ventyx Biosciences Send Eli Lilly Stock Soaring in 2026? (Motley Fool)
06:45AM	BMO Reaffirms Eli Lilly and Company (LLY) as an Obesity Market Leader (Insider Monkey)
Jan-16-26 10:05PM	This Company Is Doubling Down on AI. Is the Stock a Buy? (Motley Fool)
07:20PM	Eli Lilly: A Strong Player in the Pharmaceutical Arena (Motley Fool)
05:18PM	Stocks to Watch Friday Recap: J.B. Hunt, Salesforce, PNC (The Wall Street Journal)
04:12PM	Loading…
04:12PM	Novo's Wegovy Pill Is Following In Zepbound's Footsteps And It's Only Been One Week (Investor's Business Daily)
03:14PM	From OpenAIs offices to a deal with Eli Lilly how Chai Discovery became one of the flashiest names in AI drug development (TechCrunch)
11:19AM	Novo Nordisk's Wegovy Weight Loss Pill Has a Strong Launch-and Other Reasons the Stock Is Rising (Barrons.com)
01:43PM	Stocks to Watch Friday: J.B. Hunt, PNC, Verizon (The Wall Street Journal)
01:27PM	Stock Market Today: Dow, S&P Waffle As Battered Obesity Drug Giant Soars (Live Coverage) (Investor's Business Daily)
01:06PM	Eli Lilly vs. Novo Nordisk: Which Is the Better Stock Buy? (Motley Fool)
12:59PM	Novo Nordisk Stock Jumps. The Wegovy Pill Is Back in Focus (GuruFocus.com)
10:47AM	LLY Stock Falls After FDA Reportedly Delays Obesity Drug Ruling (Zacks)
10:22AM	Novo shares jump on 'encouraging' Wegovy pill scripts data, analysts say (Reuters Videos)
10:05AM	Nvidia and Eli Lilly Are Partnering on a $1 Billion Lab. Here's What Investors Need to Know. (Motley Fool)
09:35AM	Loading…
09:35AM	Why A 'Solid' First Week For Oral Wegovy Bodes Well For Novo And Lilly (Investor's Business Daily)
09:00AM	Investors Heavily Search Eli Lilly and Company (LLY): Here is What You Need to Know (Zacks)
07:37AM	Novo Nordisk Stock Rises After U.K. Approves Higher Wegovy Dose for Weight Loss (Barrons.com)
06:58AM	Shares in Novo Nordisk spike sharply after U.K. regulator approves higher Wegovy dosage (MarketWatch)
Jan-15-26 07:05PM	3 Unstoppable Stocks to Buy in 2026 and Hold Forever (Motley Fool)
04:40PM	Amgen's Weight-Loss Drug Shows Promise With Less Frequent Dosing (Barrons.com)
04:33PM	Stocks Boosted by Chip Demand Optimism (Barchart)
03:10PM	Trump unveils his 'Great Healthcare Plan.' Analysts don't expect much of an impact. (MarketWatch)
02:59PM	Novo Nordisk Stock Dips As Company Faces GLP-1 Antitrust Lawsuit (Benzinga)
02:25PM	Eli Lilly Stock Slips After Antitrust Lawsuit Against GLP-1 Providers (Benzinga)
02:09PM	State Street's crypto push, FDA delays review of Eli Lilly GLP-1 (Yahoo Finance Video)
01:11PM	FDA delays Eli Lilly's weight-loss pill, Reddit stock stumbles (Yahoo Finance Video)
01:11PM	Wall Street Soars Near Records, AMD And ASML Jump 6%: What's Moving Markets Thursday? (Benzinga)
12:51PM	Why Eli Lilly (LLY) Stock Is Down Today (StockStory)
11:51AM	Half of GLP-1 users ditch their injections - and some are turning to other weight-loss methods instead (MarketWatch)
11:39AM	Loading…
11:39AM	Where is Eli Lilly and Company (LLY) Headed According to Analysts? (Insider Monkey)
11:07AM	Structure Therapeutics CEO Says Compounding Threat Looms For Future Obesity Treatments (Benzinga)
10:17AM	How Will Mounjaro and Zepbound Sales Aid LLY's Upcoming Q4 Results? (Zacks)
10:15AM	JPM26: Eli Lilly highlights Lp(a) drugs as cardiovascular growth focus (Clinical Trials Arena)
09:41AM	JPM26: Eli Lillys obesity drugs target commercial and governmental access (Pharmaceutical Technology)
09:35AM	Novo Nordisk stock target raised at UBS ahead of Wegovy Pill launch (Investing.com)
08:26AM	FDA Shows Caution, Delays Trump-Backed Fast-Track Drugs Over Risks (Benzinga)
08:26AM	Why Merck's 32% Rally Isn't Enough to Change the Bearish View (Zacks)
Jan-14-26 11:13PM	JPM26: Novo Nordisk reshapes its strategy under new CEO (Pharmaceutical Technology)
11:04PM	JPM26: Eli Lilly enters 2026 with strong momentum given pipeline innovation (Pharmaceutical Technology)
03:51PM	Nvidia Eyes First Breakout Of 2026 But Resistance Remains (Investor's Business Daily)
02:46PM	Musk In The Rearview: Linda Yaccarino Puts X Behind Her To Become Tom Brady's Boss (Benzinga)
02:35PM	Eli Lilly's Most Promising Weight Loss Drug May Come With a Surprising Benefit: Pain Relief (Motley Fool)
01:33PM	Why Eli Lilly Stock Gained 39.2% In 2025 (Motley Fool)
12:23PM	Nvidia-Eli Lilly Tie-Up Shows Why AI Drug Discovery Is The Next ETF Battleground (Benzinga)
11:35AM	Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030 (Motley Fool)
09:59AM	JPM26: Paying cash for obesity drugs, renewed IPO optimism and pharmas cell therapy view (BioPharma Dive)
09:50AM	Here's Why Eli Lilly (LLY) is a Strong Momentum Stock (Zacks)
09:31AM	A Fresh IPO That Long-Term Investors Shouldn't Ignore (MarketBeat)
08:52AM	Is It Time to Dump Your Shares of Eli Lilly? (Motley Fool)
08:05AM	Nvidia Eyes First Breakout Of 2026. These Clues - And An Innovative Deal With Eli Lilly - Bode Well. (Investor's Business Daily)
07:45AM	PFE Market Cap Falls More Than $7B in a Month: How to Play the Stock (Zacks)
06:51AM	Lilly, chasing Novo, expects second-quarter FDA decision on obesity pill (BioPharma Dive)
02:53AM	Jim Cramer Calls Nvidia, Eli Lilly Partnership 'Monumental Effort' To 'Speed Up' Critical Drug Creation (Benzinga)
02:37AM	Lilly, Novo test direct-to-employer approach that could cut out PBMs and lower costs (Pharma Voice)
Jan-13-26 05:29PM	Eli Lilly Stock Rallies as Ventyx Deal Calms Wegovy Concerns (MarketBeat)
03:00PM	Eli Lilly CFO: Weight-loss pill could have 20% global penetration (Yahoo Finance Video)
02:25PM	Novo Nordisk CEO warns of international competition headwinds, cites Lilly (Investing.com)
01:20PM	FDA Says No Clear Link Found Between Popular Weight Loss Drugs And Suicidal Thoughts, Review Ongoing (Benzinga)
12:12PM	Eli Lilly teams up with Nvidia on AI lab: CFO explains why (Yahoo Finance Video)
12:12PM	Dow Jones Retail Giant Amazon Stock Eyes Latest Buy Point (Investor's Business Daily)
11:12AM	Eli Lilly CEO David Ricks on $1T market value, obesity pill launch and drug pipeline outlook (CNBC TV)
10:37AM	Nvidia, Eli Lilly Launch $1 Billion AI Lab To Build Meds (Benzinga)
10:35AM	Eli Lilly vs Novo Nordisk: Which Company Will Dominate the Weight Loss Drug Market in 2026? (Motley Fool)
10:32AM	The Zacks Analyst Blog Highlights Microsoft, Eli Lilly, Lam Research and Ampco-Pittsburgh (Zacks)
10:07AM	Nvidia Is Driving A 70% Cost Crash In Drug Discovery - Lilly Just Bet $1 Billion On It (Benzinga)
09:58AM	Novo Nordisk Soars 19% in a Month: How Should You Play the Stock? (Zacks)
09:02AM	Can Novo Nordisk Unseat Eli Lilly as the Weight Loss Drug Leader in 2026? (Motley Fool)
07:52AM	What to Expect From Eli Lillys Q4 2025 Earnings Report (Barchart)
06:53AM	Health Care Roundup: Market Talk (The Wall Street Journal)
06:27AM	Eli Lilly Stock Rises on $1 Billion AI Bet With Nvidia (GuruFocus.com)
05:24AM	AbbVie Strikes a $100 Billion Deal With Trump. How the Drugmaker Will Dodge Tariffs. (Barrons.com)
Jan-12-26 06:42PM	Pfizer CEO plans for soaring consumer market for obesity drugs akin to Viagra (Reuters)
05:45PM	Eli Lilly (LLY) Laps the Stock Market: Here's Why (Zacks)
05:45PM	3 retail trends to watch in 2026, according to NRF 2026 (Yahoo Finance Video)
05:04PM	Health Care Roundup: Market Talk (The Wall Street Journal)
04:31PM	Nvidia Partners With Biotech Firms On AI Drug Discovery (Investor's Business Daily)
04:29PM	Nvidia Stock Closes Flat. The Chip Maker Is Launching an AI Lab with Eli Lilly. (Barrons.com)
04:21PM	Expect a Busy Year in Obesity Drugs as New Pills Hit the Market (Barrons.com)
04:16PM	Top Stock Reports for Microsoft, Eli Lilly & Lam Research (Zacks)
01:25PM	JPM26: Eli Lilly and NVIDIA deepen ties with $1bn AI partnership (Medical Device Network)
01:14PM	TSMC rises on reported USTaiwan deal, Nvidia & Eli Lilly team up (Yahoo Finance Video)
01:08PM	Tempus AI's Pharma Momentum Accelerates (GuruFocus.com)
01:06PM	BioAge Rockets As It Takes On Eli Lilly's Takeover Play, Ventyx Bio (Investor's Business Daily)
12:48PM	Eli Lilly and Nvidia Make $1 Billion AI Bet to Revolutionize Pharmas Future (24/7 Wall St.)
11:38AM	'Biotech Super Bowl' Lands With a Thud. Stocks Slide on Lack of Deal News. (Barrons.com)
11:34AM	Nvidia, Eli Lilly announce $1 billion investment in AI drug discovery lab (Yahoo Finance)
11:17AM	JPM26: Eli Lilly reportedly eyes 15bn takeover of Abivax (Pharmaceutical Technology)
10:50AM	Nvidia Stock Slips. The Chip Maker Is Launching an AI Lab with Eli Lilly. (Barrons.com)
10:30AM	Nvidia and Eli Lilly are launching an AI drug discovery lab (Quartz)
10:27AM	Nvidia Partners With Eli Lilly on AI Drug Laboratory (Bloomberg)
09:45AM	Here's Why Eli Lilly (LLY) is a Strong Growth Stock (Zacks)
09:30AM	This French Biotech Stock Surged 1700% in 2025. Eli Lilly Is Taking an Interest. (Barrons.com)
06:14AM	Abivax shares surge after report flags continued Eli Lilly takeover interest (Investing.com)
05:47AM	Tempus AI Stock Soars After Posting Triple-Digit Diagnostics Growth (Benzinga)
05:03AM	Abivax Surges on Report Ely Lily is Preparing $17.5 Billion Bid (The Wall Street Journal)
05:03AM	Abivax Surges on Report Ely Lilly is Preparing $17.5 Billion Bid (The Wall Street Journal)
05:03AM	Abivax Surges on Report Eli Lilly is Preparing $17.5 Billion Bid (The Wall Street Journal)
03:10AM	Markets Last Week: Defense Stocks Rose, Beer Beat, Pharma Deal (The Wall Street Journal)
Jan-11-26 08:31PM	Eli Lilly Study Finds Zepbound Dual Treatment Improves Arthritis, Helps Patients Lose Weight (Benzinga)

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
LILLY ENDOWMENT INC	10% Owner	Jan 07 '26	Sale	1103.48	292,148	322,380,730	91,896,978	Jan 08 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jan 05 '26	Sale	1085.01	1,390	1,508,165	92,189,126	Jan 06 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Dec 29 '25	Sale	1085.04	3,593	3,898,531	92,190,516	Dec 30 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Dec 24 '25	Sale	1085.17	2,629	2,852,920	92,194,109	Dec 29 04:05 PM
LILLY ENDOWMENT INC	10% Owner	Dec 23 '25	Sale	1085.04	240	260,409	92,196,738	Dec 29 04:00 PM
LILLY ENDOWMENT, INC.	10% Owner	Dec 23 '25	Proposed Sale	1076.48	300,000	322,944,000		Dec 23 12:52 PM
LILLY ENDOWMENT INC	10% Owner	Nov 25 '25	Sale	1109.30	15,632	17,340,625	92,196,978	Nov 26 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 25 '25	Sale	1095.35	147,061	161,082,640	92,212,610	Nov 26 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 24 '25	Sale	1068.52	142,307	152,058,091	92,359,671	Nov 25 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 21 '25	Sale	1058.66	105,326	111,504,098	92,501,978	Nov 24 04:00 PM
LILLY ENDOWMENT, INC.	10% Owner	Nov 24 '25	Proposed Sale	1059.70	305,000	323,208,500		Nov 24 03:01 PM
LILLY ENDOWMENT INC	10% Owner	Nov 20 '25	Sale	1051.66	37,148	39,067,117	92,607,304	Nov 21 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 19 '25	Sale	1051.17	167,526	176,098,702	92,644,452	Nov 20 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 18 '25	Sale	1034.78	60,213	62,306,969	92,811,978	Nov 19 04:00 PM
LILLY ENDOWMENT, INC.	10% Owner	Nov 19 '25	Proposed Sale	1030.05	310,000	319,315,500		Nov 19 03:05 PM
LILLY ENDOWMENT INC	10% Owner	Nov 17 '25	Sale	1030.68	9,886	10,189,269	92,872,191	Nov 18 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 14 '25	Sale	1030.87	178,295	183,799,044	92,882,077	Nov 17 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 13 '25	Sale	1030.26	46,606	48,016,098	93,060,372	Nov 14 04:00 PM
Zakrowski Donald A	SVP, Finance, & CAO	Nov 13 '25	Sale	1010.50	1,000	1,010,500	2,840	Nov 13 04:14 PM
LILLY ENDOWMENT INC	10% Owner	Nov 12 '25	Sale	1011.18	305,000	308,411,204	93,106,978	Nov 13 04:00 PM
LILLY ENDOWMENT, INC.	10% Owner	Nov 13 '25	Proposed Sale	1017.78	295,000	300,245,100		Nov 13 03:02 PM
LILLY ENDOWMENT INC	10% Owner	Nov 11 '25	Sale	986.64	283,131	279,347,680	93,411,978	Nov 12 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 10 '25	Sale	972.52	16,869	16,405,396	93,695,109	Nov 12 04:00 PM
LILLY ENDOWMENT, INC.	10% Owner	Nov 12 '25	Proposed Sale	988.62	305,000	301,529,100		Nov 12 03:15 PM
LILLY ENDOWMENT, INC.	10% Owner	Nov 10 '25	Proposed Sale	924.37	300,000	277,311,000		Nov 10 03:11 PM
LILLY ENDOWMENT INC	10% Owner	Nov 05 '25	Sale	951.56	40,432	38,473,442	93,711,978	Nov 06 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 05 '25	Sale	933.26	179,042	167,092,104	93,752,410	Nov 06 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 04 '25	Sale	910.72	526	479,038	93,931,452	Nov 05 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 03 '25	Sale	888.83	300,000	266,648,921	93,931,978	Nov 04 04:00 PM
LILLY ENDOWMENT, INC.	10% Owner	Nov 04 '25	Proposed Sale	896.53	220,000	197,236,600		Nov 04 03:05 PM
LILLY ENDOWMENT INC	10% Owner	Oct 31 '25	Sale	863.35	301,342	260,165,031	94,231,978	Nov 03 04:00 PM
LILLY ENDOWMENT, INC.	10% Owner	Nov 03 '25	Proposed Sale	862.86	300,000	258,858,000		Nov 03 03:06 PM
LILLY ENDOWMENT INC	10% Owner	Oct 10 '25	Sale	863.24	3,658	3,157,722	94,533,320	Oct 14 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 09 '25	Sale	852.49	10,602	9,038,055	94,536,978	Oct 10 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 10 '25	Proposed Sale	855.35	305,000	260,881,750		Oct 10 02:57 PM
LILLY ENDOWMENT INC	10% Owner	Oct 08 '25	Sale	850.27	101,420	86,234,874	94,547,580	Oct 09 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 07 '25	Sale	848.01	26,795	22,722,401	94,649,000	Oct 08 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 06 '25	Sale	850.22	161,183	137,041,657	94,675,795	Oct 07 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 03 '25	Sale	837.93	192,404	161,220,401	94,836,978	Oct 06 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 06 '25	Proposed Sale	839.87	300,000	251,961,000		Oct 06 03:35 PM
LILLY ENDOWMENT INC	10% Owner	Oct 02 '25	Sale	821.55	112,596	92,503,361	95,029,382	Oct 03 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 01 '25	Sale	821.47	215,822	177,290,448	95,141,978	Oct 02 04:56 PM
LILLY ENDOWMENT INC	10% Owner	Oct 01 '25	Sale	794.15	135,193	107,363,016	95,357,800	Oct 02 04:55 PM
LILLY ENDOWMENT INC	10% Owner	Oct 02 '25	Proposed Sale	825.42	305,000	251,753,100		Oct 02 03:20 PM
LILLY ENDOWMENT INC	10% Owner	Oct 01 '25	Proposed Sale	763.00	295,000	225,085,000		Oct 01 04:08 PM
LILLY ENDOWMENT INC	10% Owner	Sep 30 '25	Sale	763.39	113,694	86,793,274	95,492,993	Oct 01 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Sep 19 '25	Sale	763.10	23,665	18,058,643	95,606,687	Sep 22 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Sep 18 '25	Sale	764.65	106,626	81,531,959	95,630,352	Sep 19 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Sep 18 '25	Proposed Sale	760.13	300,000	228,039,000		Sep 18 03:04 PM
DONALD ZAKROWSKI	Officer	Aug 28 '25	Proposed Sale	734.17	2,000	1,468,340		Aug 28 04:19 PM
Zakrowski Donald A	SVP, Finance, & CAO	Aug 28 '25	Sale	734.93	1,000	734,930	3,840	Aug 28 04:14 PM
Montarce Lucas	EVP & CFO	Aug 15 '25	Buy	691.79	715	494,627	14,685	Aug 15 04:13 PM
Alvarez Ralph	Director	Aug 13 '25	Buy	660.25	758	500,473	758	Aug 14 04:12 PM
Van Naarden Jacob	EVP & Pres., Lilly Oncology	Aug 13 '25	Buy	647.36	1,000	647,360	20,562	Aug 13 04:15 PM
Ricks David A	President, Chair, and CEO	Aug 12 '25	Buy	644.77	1,632	1,052,263	546,601	Aug 12 04:23 PM
Skovronsky Daniel	EVP, CSO & Pres. LRL & LLY Imm	Aug 12 '25	Buy	634.40	1,000	634,405	137,660	Aug 12 04:20 PM
Sulzberger Gabrielle	Director	Aug 12 '25	Buy	641.18	117	75,018	2,703	Aug 12 04:19 PM
Fyrwald J Erik	Director	Aug 12 '25	Buy	642.33	1,565	1,005,242	74,578	Aug 12 04:17 PM
Yuffa Ilya	EVP&Pres, LLY USA&Global Capab	Aug 11 '25	Sale	627.01	1,250	783,762	26,260	Aug 12 04:16 PM
JACKSON JAMERE	Director	Aug 08 '25	Buy	639.56	200	127,913	9,402	Aug 08 04:20 PM
Seymour Melissa	EVP, Global Quality	Aug 01 '25	Option Exercise	0.00	952	0	952	Aug 04 04:16 PM
LILLY ENDOWMENT INC	10% Owner	Jul 24 '25	Sale	805.07	280,000	225,419,259	95,736,978	Jul 25 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jul 24 '25	Proposed Sale	798.89	280,000	223,689,200		Jul 24 03:01 PM
Zakrowski Donald A	SVP, Finance, & CAO	May 27 '25	Sale	716.41	1,000	716,410	4,840	May 27 04:13 PM
Yuffa Ilya	EVP & President, LLY Int'l	May 14 '25	Sale	749.24	1,250	936,550	27,510	May 15 04:17 PM
Yuffa Ilya	Officer	May 14 '25	Proposed Sale	749.24	2,500	1,873,100		May 14 12:25 PM
DONALD ZAKROWSKI	Officer	Mar 13 '25	Proposed Sale	821.86	2,000	1,643,720		Mar 13 04:57 PM
Zakrowski Donald A	SVP, Finance, & CAO	Mar 13 '25	Sale	818.24	1,000	818,240	5,840	Mar 13 04:17 PM
LILLY ENDOWMENT INC	10% Owner	Mar 03 '25	Sale	928.76	220,000	204,326,151	96,016,978	Mar 04 04:00 PM
Dozier Eric	EVP, Chief People Officer	Mar 01 '25	Option Exercise	0.00	2,403	0	10,905	Mar 03 04:53 PM
Hernandez Edgardo	EVP & Pres., Mfg. Operations	Mar 01 '25	Option Exercise	0.00	2,837	0	41,009	Mar 03 04:51 PM
LILLY ENDOWMENT INC	10% Owner	Mar 03 '25	Proposed Sale	920.63	220,000	202,538,600		Mar 03 03:34 PM
LILLY ENDOWMENT INC	10% Owner	Feb 25 '25	Sale	903.07	225,000	203,190,794	96,236,978	Feb 26 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 24 '25	Sale	883.97	60,432	53,419,955	96,461,978	Feb 25 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 25 '25	Proposed Sale	881.40	225,000	198,315,000		Feb 25 03:05 PM
LILLY ENDOWMENT INC	10% Owner	Feb 21 '25	Sale	882.70	99,452	87,786,505	96,522,410	Feb 24 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 20 '25	Sale	877.99	14,685	12,893,353	96,621,862	Feb 21 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 19 '25	Sale	878.45	9,985	8,771,285	96,636,547	Feb 20 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 13 '25	Sale	879.52	35,446	31,175,396	96,646,532	Feb 14 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 13 '25	Proposed Sale	872.97	220,000	192,053,400		Feb 13 03:43 PM
Skovronsky Daniel	EVP, CSO & Pres. LRL & LLY Imm	Feb 10 '25	Sale	863.21	5,000	4,316,065	117,888	Feb 12 04:15 PM
Skovronsky Daniel	Officer	Feb 10 '25	Proposed Sale	863.19	5,000	4,315,954		Feb 10 11:44 AM
LILLY ENDOWMENT INC	10% Owner	Feb 06 '25	Sale	874.13	210,000	183,567,262	96,681,978	Feb 07 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 06 '25	Proposed Sale	842.18	210,000	176,857,800		Feb 06 04:04 PM
Yuffa Ilya	EVP & President, LLY Int'l	Feb 01 '25	Option Exercise	0.00	3,269	0	23,071	Feb 04 04:28 PM
White Anne E.	EVP & Pres, Lilly Neuroscience	Feb 01 '25	Option Exercise	0.00	3,269	0	68,838	Feb 04 04:27 PM
Van Naarden Jacob	EVP & Pres., Lilly Oncology	Feb 01 '25	Option Exercise	0.00	3,023	0	14,868	Feb 04 04:26 PM
Skovronsky Daniel	EVP, CSO & Pres. LRL & LLY Imm	Feb 01 '25	Option Exercise	0.00	8,989	0	126,892	Feb 04 04:25 PM
Ricks David A	President, Chair, and CEO	Feb 01 '25	Option Exercise	0.00	26,561	0	496,385	Feb 04 04:24 PM
Rau Diogo	EVP & CIDO	Feb 01 '25	Option Exercise	0.00	3,269	0	14,370	Feb 04 04:23 PM
Jonsson Patrik	EVP&Pres, CardMetHlth, LLY USA	Feb 01 '25	Option Exercise	0.00	3,433	0	48,016	Feb 04 04:23 PM
Hernandez Edgardo	EVP & Pres., Mfg. Operations	Feb 01 '25	Option Exercise	0.00	2,861	0	33,479	Feb 04 04:21 PM
Hakim Anat	EVP, GC & Secretary	Feb 01 '25	Option Exercise	0.00	4,904	0	20,683	Feb 04 04:19 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

LLY

Lilly(Eli) & Co

Upgrade your FINVIZ experience